JP Patent

JP7504880B2 — Ａｌｋ２阻害剤の結晶形

Assigned to Keros Therapeutics Inc · Expires 2024-06-24 · 2y expired

What this patent protects

Patent listed against ketorolac-tromethamine.

Drugs covered by this patent

ketorolac-tromethamine (KETOROLAC TROMETHAMINE)

Patent Metadata

Patent number: JP7504880B2
Jurisdiction: JP
Classification: —
Expires: 2024-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Keros Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.